New patent for Gilead Sciences drug SUNLENCA
Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four…
Source
Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four…
Source
Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
Source
Get new actionable insights and updates from BiotechBlog